<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03602378</url>
  </required_header>
  <id_info>
    <org_study_id>2181-198-03-04-18-0014</org_study_id>
    <nct_id>NCT03602378</nct_id>
  </id_info>
  <brief_title>QoL and Stress in Parents of Children With Developmental Disabilities and Chronic Disease</brief_title>
  <official_title>Quality of Life and Stress in Parents of Children With Developmental Disabilities and Chronic Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Split, School of Medicine</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>General Hospital Zadar</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Split, School of Medicine</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this cross-sectional study is to investigate the level of stress and quality of
      life in parents of children with developmental disabilities (Down syndrome, autism spectrum
      disorder, pervasive developmental disorder, cerebral palsy) and parents of children chronic
      diseases (diabetes mellitus type 1, epilepsy, asthma) compared to parents of healthy
      children.

      The investigators will analyze the level of stress, quality of life, self-esteem, optimism,
      resilience, happiness, stigmatization, depression, anxiety, sleep quality, parenting
      challenges and some physiological indicators of the stress such as level of cortisol and
      heart rate variability. Also, the investigators will measure Advanced Glycation End products
      (AGEs) in the skin.

      The investigators assume that parents of children with developmental disabilities and chronic
      diseases have higher level of stress and lower quality of life compared to the parents of
      healthy children.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Participants will be parents of children with a pervasive developmental disorder (autistic
      spectrum disorder), Down syndrome, cerebral palsy, epilepsy, diabetes mellitus type 1,
      asthma, and parents of healthy children (without difficulty and chronic disease - control
      group).

      The investigators will examine the level of stress and quality of life in parents of children
      with developmental and chronic illnesses, compared to parents of healthy children, adjusting
      for the effect of confounding factors.

      Data collection will be conducted using the questionnaire to assess personal quality of life,
      family quality of life, general and parental stress levels. Additionally, potential
      confounding or mediating factors will be measured and taken into account: stress resilience,
      cohesion, self-esteem, optimism, perception of happiness, stigmatization, depression,
      anxiety, sleep quality and parenting challenges. Also, socio-demographics parameters, short
      medical history, lifestyle habits and the perception of life difficulties will be assessed.
      The questionnaire will be filled by paper-pencil method with anticipated duration of about 45
      minutes.

      The investigators will also measure several physiological indicators - salivary cortisol,
      heart rate variability, blood pressure and Advanced Glycation End products (AGEs).

      Saliva will be taken in order to analyze the cortisol level, using Salivette Sarstedt REF
      51.1534.500. Participants will be taken five saliva samples during the day because of the
      physiological variability of cortisol (first one around 22:00 hours, second right after
      waking up, then 15, 30 and 60 minutes after awaking). Each subject will receive detailed
      instructions on how to take saliva, with written instructions. Thirty minutes before
      sampling, the subjects has to restrain from eating, drinking, smoking or brushing teeth. In
      case of acute illness, inflammation or disease in the oral cavity, the sampling will be
      delayed. After taking the sample, tubes will be stored in the refrigerator. In the
      laboratory, the sample will be centrifuged for two minutes to remove saliva from cotton, and
      saliva samples will be frozen. Cortisol analysis will be done using ECLIA
      (Electrochemiluminous Absorption Method).

      The electrocardiogram (ECG) will be recorded using the Medilog AR12 Plus Holter device, which
      will also be used to record heart rate variability (HRV) during 5 minutes. HRV will also be
      recorded using the Polar V800 (also during 5 minutes). Kubios software will be used for HRV
      analysis.

      AGE Reader, a non-invasive device will be used for measuring the autofluorescence in the
      skin, reflecting the level of Advanced Glycation End products (AGEs).

      Omrom M6 Comfort is an automatic device which will be used to measure blood pressure and
      pulse.

      Anthropometric parameters will be measured (body weight, height, neck circumference, waist
      and hip circumference).

      Statistical analysis will be carried out using statistical program MedCalc. Initial analysis
      of results will include analysis of the distribution of variables using the
      Kolmogorov-Smirnov test. If the distribution of numerical variables will be normal,
      parametric statistics will be applied. The confounding factors will be controlled by using
      appropriate statistical tests.

      Participation of parents in this study is voluntary. If a parent decides to participate in
      this study, the code will be assigned. In that way, all data, measured parameters, and saliva
      samples will be encoded, and the personal data of the respondents will be completely
      invisible. It will not be possible to identity an individual parent. All researchers must and
      will be protecting confidentiality of data.
    </textblock>
  </detailed_description>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date type="Actual">April 2, 2018</start_date>
  <completion_date type="Anticipated">May 2, 2021</completion_date>
  <primary_completion_date type="Anticipated">April 2, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Quality of life in parents of children with developmental disability and chronic disease, and healthy children.</measure>
    <time_frame>1 day</time_frame>
    <description>Subjects will complete the questionnaires about quality of life. A total 26 item in the WHOQOL-BREF produces four domain scores: physical, psychological, social relationships and environment domain (Likert type scale ranging from 1- strongly disagree to 5 - strongly agree).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Stress in parents of children with developmental disability and chronic disease, and healthy children.</measure>
    <time_frame>1 days</time_frame>
    <description>Subjects will complete the questionnaires about parental stress. Parental Stress Scale consists of 18 item self report scale (Likert type scale ranging from 1-strongly disagree, 2-disagree, 3-undecided, 4-agree 5-strongly agree). Items represent positive (e.g. emotional benefits, personal development) and negative (demands on resources, restrictions) themes of parenthood.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Family quality of life</measure>
    <time_frame>1 day</time_frame>
    <description>A total 25 items in FQOL scale keyed for five domains scores: family interaction, parenting, emotional well-being, physical / material well-being and disability-related support (Likert type scale satisfaction are rated on a 5-point scale, where 1- very dissatisfied, 3-neither satisfied nor dissatisfied, and 5-very satisfied). Scores are scaled in a positive direction (i.e. higher scores denote higher quality of life).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Perceived Stress Scale</measure>
    <time_frame>1 day</time_frame>
    <description>Perceived Stress Scale consists of 10 items (Likert type scale ranging from 0-never, 1-almost never, 2-sometimes,3-fairly often, 4-very often). Higher scores indicating greater levels of stress.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Salivary cortisol concentration in parents of children with developmental disability, chronic disease and parents of healthy children.</measure>
    <time_frame>1 day</time_frame>
    <description>5 samples of saliva (first sample before around 22:00 and other samples the next morning, after awakening (00, 15, 30 and 60 minutes)).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Heart rate variability in parents of children with developmental disability, chronic disease and parents of healthy children</measure>
    <time_frame>1 day</time_frame>
    <description>Holter Medilog AR12 Plus - electrocardiogram and Polar V800 with sensor - during 5 minutes</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Advanced glycation end products in parents of children with developmental disability, chronic disease and parents of healthy children.</measure>
    <time_frame>1 day</time_frame>
    <description>AGE reader for measuring advanced glycation end products. Higher results indicating greater cardiovascular risk.</description>
  </secondary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Anticipated">592</enrollment>
  <condition>Developmental Disability</condition>
  <condition>Chronic Disease</condition>
  <condition>Down Syndrome</condition>
  <condition>Autism Spectrum Disorder</condition>
  <condition>Pervasive Developmental Disorder</condition>
  <condition>Cerebral Palsy</condition>
  <condition>Diabetes Mellitus, Type 1</condition>
  <condition>Epilepsy</condition>
  <condition>Asthma</condition>
  <condition>Stress</condition>
  <arm_group>
    <arm_group_label>Parents of children with disability</arm_group_label>
    <description>parents of children with developmental disabilities (Down syndrome, autism spectrum disorder, pervasive developmental disorder, cerebral palsy), age 20-50, salivary cortisol, Holter Medilog AR12 Plus, Polar V800, AGE reader</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Parents of children with chronic disease</arm_group_label>
    <description>parents of children chronic disease (diabetes mellitus type 1, epilepsy, asthma), age 20-50, salivary cortisol, Holter Medilog AR12 Plus, Polar V800, AGE reader</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Parents of healthy children</arm_group_label>
    <description>parents of healthy children, age 20-50, salivary cortisol, Holter Medilog AR12 Plus, Polar V800, AGE reader</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>salivary cortisol</intervention_name>
    <description>5 samples of saliva (first sample before around 22:00 and other samples the next morning, after awakening (00, 15, 30 and 60 minutes).</description>
    <arm_group_label>Parents of children with chronic disease</arm_group_label>
    <arm_group_label>Parents of children with disability</arm_group_label>
    <arm_group_label>Parents of healthy children</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Holter Medilog AR12 Plus</intervention_name>
    <description>Holter Medilog AR12 Plus - electrocardiogram during 5 minutes for measuring HRV</description>
    <arm_group_label>Parents of children with chronic disease</arm_group_label>
    <arm_group_label>Parents of children with disability</arm_group_label>
    <arm_group_label>Parents of healthy children</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Polar V800</intervention_name>
    <description>Polar V800 with sensor - during 5 minutes for measuring HRV</description>
    <arm_group_label>Parents of children with chronic disease</arm_group_label>
    <arm_group_label>Parents of children with disability</arm_group_label>
    <arm_group_label>Parents of healthy children</arm_group_label>
    <other_name>Polar V800 with sensor</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>AGE reader</intervention_name>
    <description>for measuring Advanced Glycation End products (AGEs)</description>
    <arm_group_label>Parents of children with chronic disease</arm_group_label>
    <arm_group_label>Parents of children with disability</arm_group_label>
    <arm_group_label>Parents of healthy children</arm_group_label>
    <other_name>Advanced glycation end products reader</other_name>
    <other_name>AGEs reader</other_name>
  </intervention>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      saliva samples
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Parents of children with Down syndrome, pervasive developmental disorder (autistic spectrum
        disorder), cerebral palsy, epilepsy, diabetes type 1, asthma, and parents of healthy
        children (without difficulties and chronic diseases - control group).
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  subject are parents between 20 and 50 years,

          -  subject are parents of the child with developmental disability (Down syndrome, autism
             spectrum disorder, pervasive developmental disorder, cerebral palsy) or chronic
             disease (diabetes mellitus type 1, epilepsy, asthma) - the ages of the child between 4
             and 12 years.

        Exclusion Criteria:

          -  severe psychiatry and severe chronic illnesses of parents

          -  ischemic heart disease

          -  cardiomyopathy

          -  heart arrhythmia

          -  malignant hypertension

          -  diabetic neuropathy

          -  transplantation of heart and other organs

          -  tetraplegia

          -  diseases of the hypothalamus and pituitary and adrenal gland

          -  corticosteroid therapy

          -  antiarrhythmic therapy

          -  therapy of β-blockers

          -  therapy of sedatives

          -  therapy of anxiolytics

          -  chemotherapy

          -  night shift work

          -  breastfeeding (active or completed within less 6 months)

          -  pregnancy

          -  diagnose of child less than 6 months

          -  parents of children with other severe chronic or rare diseases such as malignant
             disease, haemophilia, phenylketonuria, neurofibromatosis.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>MARIJA LJUBICIC, RN, MSN</last_name>
    <role>Principal Investigator</role>
    <affiliation>General hospital Zadar, Department of Pediatrics</affiliation>
  </overall_official>
  <overall_official>
    <last_name>IVANA KOLCIC, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Split, School of Medicine</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University Hospital Split</name>
      <address>
        <city>Split</city>
        <zip>21000</zip>
        <country>Croatia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ivana Kolcic</name>
      <address>
        <city>Split</city>
        <zip>23000</zip>
        <country>Croatia</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Croatia</country>
  </location_countries>
  <reference>
    <citation>Kleinman JM, Robins DL, Ventola PE, Pandey J, Boorstein HC, Esser EL, Wilson LB, Rosenthal MA, Sutera S, Verbalis AD, Barton M, Hodgson S, Green J, Dumont-Mathieu T, Volkmar F, Chawarska K, Klin A, Fein D. The modified checklist for autism in toddlers: a follow-up study investigating the early detection of autism spectrum disorders. J Autism Dev Disord. 2008 May;38(5):827-39.</citation>
    <PMID>17882539</PMID>
  </reference>
  <reference>
    <citation>Turner LM, Stone WL. Variability in outcome for children with an ASD diagnosis at age 2. J Child Psychol Psychiatry. 2007 Aug;48(8):793-802.</citation>
    <PMID>17683451</PMID>
  </reference>
  <reference>
    <citation>Eaves LC, Ho HH. The very early identification of autism: outcome to age 4 1/2-5. J Autism Dev Disord. 2004 Aug;34(4):367-78.</citation>
    <PMID>15449513</PMID>
  </reference>
  <reference>
    <citation>Bella GP, Garcia MC, Spadari-Bratfisch RC. Salivary cortisol, stress, and health in primary caregivers (mothers) of children with cerebral palsy. Psychoneuroendocrinology. 2011 Jul;36(6):834-42. doi: 10.1016/j.psyneuen.2010.11.005. Epub 2010 Dec 10.</citation>
    <PMID>21146316</PMID>
  </reference>
  <reference>
    <citation>Stalder T, Kirschbaum C, Kudielka BM, Adam EK, Pruessner JC, Wüst S, Dockray S, Smyth N, Evans P, Hellhammer DH, Miller R, Wetherell MA, Lupien SJ, Clow A. Assessment of the cortisol awakening response: Expert consensus guidelines. Psychoneuroendocrinology. 2016 Jan;63:414-32. doi: 10.1016/j.psyneuen.2015.10.010. Epub 2015 Oct 20. Review.</citation>
    <PMID>26563991</PMID>
  </reference>
  <reference>
    <citation>Heart rate variability. Standards of measurement, physiological interpretation, and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Eur Heart J. 1996 Mar;17(3):354-81.</citation>
    <PMID>8737210</PMID>
  </reference>
  <reference>
    <citation>Billman GE. Heart rate variability - a historical perspective. Front Physiol. 2011 Nov 29;2:86. doi: 10.3389/fphys.2011.00086. eCollection 2011.</citation>
    <PMID>22144961</PMID>
  </reference>
  <reference>
    <citation>Baba M, Ohkura M, Koga K, Nishiuchi K, Herrera LR, Matsuse R, Inoue T. Analysis of salivary cortisol levels to determine the association between depression level and differences in circadian rhythms of shift-working nurses. J Occup Health. 2015;57(3):237-44. doi: 10.1539/joh.14-0079-OA. Epub 2015 Mar 6.</citation>
    <PMID>25752657</PMID>
  </reference>
  <reference>
    <citation>Karhula K, Härmä M, Sallinen M, Lindholm H, Hirvonen A, Elovainio M, Kivimäki M, Vahtera J, Puttonen S. Salivary cortisol and alpha-amylase: Is there consistency between psychosocial stress test and burdensome work shifts? J Occup Environ Hyg. 2017 Dec;14(12):1003-1010. doi: 10.1080/15459624.2017.1350786.</citation>
    <PMID>28692340</PMID>
  </reference>
  <reference>
    <citation>Niu SF, Chung MH, Chu H, Tsai JC, Lin CC, Liao YM, Ou KL, O'Brien AP, Chou KR. Differences in cortisol profiles and circadian adjustment time between nurses working night shifts and regular day shifts: A prospective longitudinal study. Int J Nurs Stud. 2015 Jul;52(7):1193-201. doi: 10.1016/j.ijnurstu.2015.04.001. Epub 2015 Apr 8.</citation>
    <PMID>25900684</PMID>
  </reference>
  <reference>
    <citation>Simon CD, Adam EK, McKinney CO, Krohn JB, Shalowitz MU. Breastfeeding, Bed-Sharing, and Maternal Cortisol. Clin Pediatr (Phila). 2016 May;55(5):470-8. doi: 10.1177/0009922815601981. Epub 2015 Sep 1.</citation>
    <PMID>26330120</PMID>
  </reference>
  <reference>
    <citation>Tu MT, Lupien SJ, Walker CD. Diurnal salivary cortisol levels in postpartum mothers as a function of infant feeding choice and parity. Psychoneuroendocrinology. 2006 Aug;31(7):812-24. Epub 2006 May 23.</citation>
    <PMID>16716531</PMID>
  </reference>
  <reference>
    <citation>Rogers SL, Hughes BA, Tomlinson JW, Blissett J. Cortisol metabolism, postnatal depression and weight changes in the first 12 months postpartum. Clin Endocrinol (Oxf). 2016 Dec;85(6):881-890. doi: 10.1111/cen.13150. Epub 2016 Aug 11.</citation>
    <PMID>27374760</PMID>
  </reference>
  <reference>
    <citation>Orta OR, Gelaye B, Bain PA, Williams MA. The association between maternal cortisol and depression during pregnancy, a systematic review. Arch Womens Ment Health. 2018 Feb;21(1):43-53. doi: 10.1007/s00737-017-0777-y. Epub 2017 Sep 24. Review.</citation>
    <PMID>28942465</PMID>
  </reference>
  <reference>
    <citation>Wolfram M, Bellingrath S, Kudielka BM. The cortisol awakening response (CAR) across the female menstrual cycle. Psychoneuroendocrinology. 2011 Jul;36(6):905-12. doi: 10.1016/j.psyneuen.2010.12.006. Epub 2011 Jan 14.</citation>
    <PMID>21237574</PMID>
  </reference>
  <reference>
    <citation>Hodgson NA, Granger DA. Collecting saliva and measuring salivary cortisol and alpha-amylase in frail community residing older adults via family caregivers. J Vis Exp. 2013 Dec 18;(82):e50815. doi: 10.3791/50815.</citation>
    <PMID>24378361</PMID>
  </reference>
  <reference>
    <citation>Foody C, James JE, Leader G. Parenting stress, salivary biomarkers, and ambulatory blood pressure: a comparison between mothers and fathers of children with autism spectrum disorders. J Autism Dev Disord. 2015 Apr;45(4):1084-95. doi: 10.1007/s10803-014-2263-y.</citation>
    <PMID>25287900</PMID>
  </reference>
  <reference>
    <citation>Development of the World Health Organization WHOQOL-BREF quality of life assessment. The WHOQOL Group. Psychol Med. 1998 May;28(3):551-8.</citation>
    <PMID>9626712</PMID>
  </reference>
  <reference>
    <citation>Berry JO, Jones WH. The parental stress scale: Initial psychometric evidence. Journal of Social and Personal Relationships 1995;12:463-72</citation>
  </reference>
  <reference>
    <citation>Bourke-Taylor H, Law M, Howie L, Pallant JF. Development of the Child's Challenging Behaviour Scale (CCBS) for mothers of school-aged children with disabilities. Child Care Health Dev. 2010 Jul;36(4):491-8. doi: 10.1111/j.1365-2214.2009.01055.x. Epub 2009 Dec 29.</citation>
    <PMID>20047597</PMID>
  </reference>
  <reference>
    <citation>Buysse DJ, Reynolds CF 3rd, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res. 1989 May;28(2):193-213.</citation>
    <PMID>2748771</PMID>
  </reference>
  <reference>
    <citation>Cohen S, Kamarck T, Mermelstein R. A global measure of perceived stress. J Health Soc Behav. 1983 Dec;24(4):385-96.</citation>
    <PMID>6668417</PMID>
  </reference>
  <reference>
    <citation>Crandal R. The measurement of self-esteem and related constructs, Pp. 80-82 in JP Robinson and PR Shaver (Eds), Measures of social psychological attitudes. Revised edition. Ann Arbor: ISR 1973.</citation>
  </reference>
  <reference>
    <citation>Gosling SD, Rentfrow PJ, Swann WB. A very brief measure of the Big-Five personality domains. Journal of Research in personality 2003;37:504-28.</citation>
  </reference>
  <reference>
    <citation>Hoffman L, Marquis J, Poston D, Summers JA, Turnbull A. Assessing Family Outcomes: Psychometric Evaluation of the Beach Center Family Quality of Life Scale. Journal of Marriage and Family 2006;68:1069-83.</citation>
  </reference>
  <reference>
    <citation>Lupien SJ, Seguin F. How to measure stress in humans. Centre for Studies in Human Stress 2013.</citation>
  </reference>
  <reference>
    <citation>Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001 Sep;16(9):606-13.</citation>
    <PMID>11556941</PMID>
  </reference>
  <reference>
    <citation>Lyubomirsky S, Lepper HS. A measure of subjective happiness: Preliminary reliability and construct validation. Social indicators research 1999;46:137-55.</citation>
  </reference>
  <reference>
    <citation>Mak WWS, Cheung RYM. Affiliate Stigma Among Caregivers of People with Intellectual Disability or Mental Illness. J Appl Res Intellect Disabil 2008;21:532-45.</citation>
  </reference>
  <reference>
    <citation>Poston D, Turnbull A, Park J, Mannan H, Marquis J, Wang M. Family quality of life: a qualitative inquiry. Ment Retard. 2003 Oct;41(5):313-28.</citation>
    <PMID>12962536</PMID>
  </reference>
  <reference>
    <citation>Smith BW, Dalen J, Wiggins K, Tooley E, Christopher P, Bernard J. The brief resilience scale: assessing the ability to bounce back. Int J Behav Med. 2008;15(3):194-200. doi: 10.1080/10705500802222972.</citation>
    <PMID>18696313</PMID>
  </reference>
  <reference>
    <citation>Spitzer RL, Kroenke K, Williams JB, Löwe B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006 May 22;166(10):1092-7.</citation>
    <PMID>16717171</PMID>
  </reference>
  <reference>
    <citation>Tolan PH, Gorman-Smith D, Huesmann LR, Zelli A. Assessment of family relationship characteristics: A measure to explain risk for antisocial behavior and depression among urban youth. Psychological Assessment 1997;9:212.</citation>
  </reference>
  <reference>
    <citation>Yaneva M, Mosnier-Pudar H, Dugué MA, Grabar S, Fulla Y, Bertagna X. Midnight salivary cortisol for the initial diagnosis of Cushing's syndrome of various causes. J Clin Endocrinol Metab. 2004 Jul;89(7):3345-51.</citation>
    <PMID>15240613</PMID>
  </reference>
  <reference>
    <citation>El-Farhan N, Rees DA, Evans C. Measuring cortisol in serum, urine and saliva - are our assays good enough? Ann Clin Biochem. 2017 May;54(3):308-322. doi: 10.1177/0004563216687335. Epub 2017 Mar 16. Review.</citation>
    <PMID>28068807</PMID>
  </reference>
  <reference>
    <citation>Kirschbaum C, Hellhammer DH. Salivary cortisol in psychoneuroendocrine research: recent developments and applications. Psychoneuroendocrinology. 1994;19(4):313-33. Review.</citation>
    <PMID>8047637</PMID>
  </reference>
  <reference>
    <citation>Heart rate variability: standards of measurement, physiological interpretation and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Circulation. 1996 Mar 1;93(5):1043-65.</citation>
    <PMID>8598068</PMID>
  </reference>
  <reference>
    <citation>Sammito S, Böckelmann I. Reference values for time- and frequency-domain heart rate variability measures. Heart Rhythm. 2016 Jun;13(6):1309-16. doi: 10.1016/j.hrthm.2016.02.006. Epub 2016 Feb 12.</citation>
    <PMID>26883166</PMID>
  </reference>
  <reference>
    <citation>Nunan D, Sandercock GR, Brodie DA. A quantitative systematic review of normal values for short-term heart rate variability in healthy adults. Pacing Clin Electrophysiol. 2010 Nov;33(11):1407-17. doi: 10.1111/j.1540-8159.2010.02841.x. Review.</citation>
    <PMID>20663071</PMID>
  </reference>
  <reference>
    <citation>Giles D, Draper N, Neil W. Validity of the Polar V800 heart rate monitor to measure RR intervals at rest. Eur J Appl Physiol. 2016 Mar;116(3):563-71. doi: 10.1007/s00421-015-3303-9. Epub 2015 Dec 26.</citation>
    <PMID>26708360</PMID>
  </reference>
  <reference>
    <citation>Tarvainen MP, Niskanen JP, Lipponen JA, Ranta-Aho PO, Karjalainen PA. Kubios HRV--heart rate variability analysis software. Comput Methods Programs Biomed. 2014;113(1):210-20. doi: 10.1016/j.cmpb.2013.07.024. Epub 2013 Aug 6.</citation>
    <PMID>24054542</PMID>
  </reference>
  <reference>
    <citation>Urfer-Maurer N, Ludyga S, Stalder T, Brand S, Holsboer-Trachsler E, Gerber M, Grob A, Weber P, Lemola S. Heart rate variability and salivary cortisol in very preterm children during school age. Psychoneuroendocrinology. 2018 Jan;87:27-34. doi: 10.1016/j.psyneuen.2017.10.004. Epub 2017 Oct 5.</citation>
    <PMID>29035709</PMID>
  </reference>
  <reference>
    <citation>Hofmann B, Jacobs K, Navarrete Santos A, Wienke A, Silber RE, Simm A. Relationship between cardiac tissue glycation and skin autofluorescence in patients with coronary artery disease. Diabetes Metab. 2015 Nov;41(5):410-5. doi: 10.1016/j.diabet.2014.12.001. Epub 2014 Dec 29.</citation>
    <PMID>25553578</PMID>
  </reference>
  <reference>
    <citation>de Vos LC, Lefrandt JD, Dullaart RP, Zeebregts CJ, Smit AJ. Advanced glycation end products: An emerging biomarker for adverse outcome in patients with peripheral artery disease. Atherosclerosis. 2016 Nov;254:291-299. doi: 10.1016/j.atherosclerosis.2016.10.012. Epub 2016 Oct 6. Review.</citation>
    <PMID>27751506</PMID>
  </reference>
  <reference>
    <citation>Grover-Páez F, Cardona-Muñoz EG, Cardona-Müller D, Guzmán-Saldívar VH, Rodríguez-De la Cerda M, Jiménez-Cázarez MB, Totsuka-Sutto SE, Alanis-Sánchez GA, Ramos-Becerra CG. Validation of the Omron HEM-7320-LA, upper arm blood pressure monitor with Intelli Wrap Technology Cuff HEM-FL1 for self-measurement and clinic use according to the European Society of Hypertension International Protocol revision 2010 in the Mexican population. Blood Press Monit. 2017 Dec;22(6):375-378. doi: 10.1097/MBP.0000000000000290.</citation>
    <PMID>28945665</PMID>
  </reference>
  <reference>
    <citation>Verberk WJ, Kessels AG, Thien T. Blood pressure measurement method and inter-arm differences: a meta-analysis. Am J Hypertens. 2011 Nov;24(11):1201-8. doi: 10.1038/ajh.2011.125. Epub 2011 Jul 21.</citation>
    <PMID>21776035</PMID>
  </reference>
  <reference>
    <citation>Ali BA, Abdelhakm AA, Abdelhameed MA, Tawfik NK. Quality of Life in Children with Type I Diabetes Mellitus (T1D) in Minia Governorate: Relationship with Mood and Family Attitudes. J Diabetes Metab 2017;8:5.</citation>
  </reference>
  <reference>
    <citation>Andrade EM, Geha LM, Duran P, Suwwan R, Machado F, do Rosário MC. Quality of Life in Caregivers of ADHD Children and Diabetes Patients. Front Psychiatry. 2016 Jul 25;7:127. doi: 10.3389/fpsyt.2016.00127. eCollection 2016.</citation>
    <PMID>27504099</PMID>
  </reference>
  <reference>
    <citation>Dardas LA, Ahmad MM. Quality of life among parents of children with autistic disorder: a sample from the Arab world. Res Dev Disabil. 2014 Feb;35(2):278-87. doi: 10.1016/j.ridd.2013.10.029. Epub 2013 Dec 4.</citation>
    <PMID>24316492</PMID>
  </reference>
  <reference>
    <citation>Gagliano A, Lamberti M, Siracusano R, Ciuffo M, Boncoddo M, Maggio R, Rosina S, Cedro C, Germanò E. A Comparison between Children with ADHD and Children with Epilepsy in Self-Esteem and Parental Stress Level. Clin Pract Epidemiol Ment Health. 2014 Dec 24;10:176-83. doi: 10.2174/1745017901410010176. eCollection 2014.</citation>
    <PMID>25614755</PMID>
  </reference>
  <reference>
    <citation>Hullmann SE, Wolfe-Christensen C, Ryan JL, Fedele DA, Rambo PL, Chaney JM, Mullins LL. Parental overprotection, perceived child vulnerability, and parenting stress: a cross-illness comparison. J Clin Psychol Med Settings. 2010 Dec;17(4):357-65. doi: 10.1007/s10880-010-9213-4.</citation>
    <PMID>21086027</PMID>
  </reference>
  <reference>
    <citation>Leung C, Tsang SK. The Chinese Parental Stress Scale: psychometric evidence using Rasch modeling on clinical and nonclinical samples. J Pers Assess. 2010 Jan;92(1):26-34. doi: 10.1080/00223890903379209.</citation>
    <PMID>20013453</PMID>
  </reference>
  <reference>
    <citation>Manee F, Ateya Y, Rassafiani M. A Comparison of the Quality of Life of Arab Mothers of Children with and without Chronic Disabilities. Phys Occup Ther Pediatr. 2016 Aug;36(3):260-71. doi: 10.3109/01942638.2015.1076558. Epub 2015 Nov 13.</citation>
    <PMID>26566139</PMID>
  </reference>
  <reference>
    <citation>Mugno D, Ruta L, D'Arrigo VG, Mazzone L. Impairment of quality of life in parents of children and adolescents with pervasive developmental disorder. Health Qual Life Outcomes. 2007 Apr 27;5:22.</citation>
    <PMID>17466072</PMID>
  </reference>
  <reference>
    <citation>Norizan A, Shamsuddin K. Predictors of parenting stress among Malaysian mothers of children with Down syndrome. J Intellect Disabil Res. 2010 Nov;54(11):992-1003. doi: 10.1111/j.1365-2788.2010.01324.x. Epub 2010 Sep 27.</citation>
    <PMID>20868445</PMID>
  </reference>
  <reference>
    <citation>Phillips BA, Conners F, Curtner-Smith ME. Parenting children with down syndrome: An analysis of parenting styles, parenting dimensions, and parental stress. Res Dev Disabil. 2017 Sep;68:9-19. doi: 10.1016/j.ridd.2017.06.010. Epub 2017 Jul 7.</citation>
    <PMID>28692948</PMID>
  </reference>
  <reference>
    <citation>Roncada C, Dias CP, Goecks S, Cidade SE, Pitrez PM. [Usefulness of the WHOQOL-BREF questionnaire in assessing the quality of life of parents of children with asthma]. Rev Paul Pediatr. 2015 Jul-Sep;33(3):268-74. doi: 10.1016/j.rpped.2015.01.007. Epub 2015 Jun 9. Portuguese.</citation>
    <PMID>26137868</PMID>
  </reference>
  <reference>
    <citation>Semakina NV, Mikhailov VA, Bagaev VI. Assessing the quality of life of families of children with epilepsy. Obozrenie psikhiatrii i meditsinskoi psikhologii im VM Bekhtereva 2012:73-6.</citation>
  </reference>
  <reference>
    <citation>Vadakedom SS, Antony JM, Padma BK, Mammen DS, Thankappan BP. Quality of life of mothers of children with Down syndrome. J Evol Med Dent Sci-JEMDS 2017;6:2939-42.</citation>
  </reference>
  <reference>
    <citation>Wolf JM, Miller GE, Chen E. Parent psychological states predict changes in inflammatory markers in children with asthma and healthy children. Brain Behav Immun. 2008 May;22(4):433-41. Epub 2007 Dec 18.</citation>
    <PMID>18068332</PMID>
  </reference>
  <reference>
    <citation>Epifanio MS, Genna V, Vitello MG, Roccella M, La Grutta S. Parenting stress and impact of illness in parents of children with coeliac disease. Pediatr Rep. 2013 Dec 19;5(4):e19. doi: 10.4081/pr.2013.e19. eCollection 2013.</citation>
    <PMID>24416498</PMID>
  </reference>
  <reference>
    <citation>Scheier MF, Carver CS, Bridges MW. Distinguishing optimism from neuroticism (and trait anxiety, self-mastery, and self-esteem): a reevaluation of the Life Orientation Test. J Pers Soc Psychol. 1994 Dec;67(6):1063-78.</citation>
    <PMID>7815302</PMID>
  </reference>
  <reference>
    <citation>Monteagudo C, Mariscal-Arcas M, Rivas A, Lorenzo-Tovar ML, Tur JA, Olea-Serrano F. Proposal of a Mediterranean Diet Serving Score. PLoS One. 2015 Jun 2;10(6):e0128594. doi: 10.1371/journal.pone.0128594. eCollection 2015.</citation>
    <PMID>26035442</PMID>
  </reference>
  <reference>
    <citation>Bassett DR Jr. International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc. 2003 Aug;35(8):1396.</citation>
    <PMID>12900695</PMID>
  </reference>
  <reference>
    <citation>Craig CL, Marshall AL, Sjöström M, Bauman AE, Booth ML, Ainsworth BE, Pratt M, Ekelund U, Yngve A, Sallis JF, Oja P. International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc. 2003 Aug;35(8):1381-95.</citation>
    <PMID>12900694</PMID>
  </reference>
  <reference>
    <citation>Chung F, Subramanyam R, Liao P, Sasaki E, Shapiro C, Sun Y. High STOP-Bang score indicates a high probability of obstructive sleep apnoea. Br J Anaesth. 2012 May;108(5):768-75. doi: 10.1093/bja/aes022. Epub 2012 Mar 8.</citation>
    <PMID>22401881</PMID>
  </reference>
  <reference>
    <citation>Chung F, Yegneswaran B, Liao P, Chung SA, Vairavanathan S, Islam S, Khajehdehi A, Shapiro CM. STOP questionnaire: a tool to screen patients for obstructive sleep apnea. Anesthesiology. 2008 May;108(5):812-21. doi: 10.1097/ALN.0b013e31816d83e4.</citation>
    <PMID>18431116</PMID>
  </reference>
  <reference>
    <citation>Johns MW. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep. 1991 Dec;14(6):540-5.</citation>
    <PMID>1798888</PMID>
  </reference>
  <reference>
    <citation>Stelmach-Mardas M, Iqbal K, Mardas M, Kostrzewska M, Piorunek T. Clinical Utility of Berlin Questionnaire in Comparison to Polysomnography in Patients with Obstructive Sleep Apnea. Adv Exp Med Biol. 2017;980:51-57. doi: 10.1007/5584_2017_7.</citation>
    <PMID>28255917</PMID>
  </reference>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>June 4, 2018</study_first_submitted>
  <study_first_submitted_qc>July 18, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">July 26, 2018</study_first_posted>
  <last_update_submitted>March 25, 2020</last_update_submitted>
  <last_update_submitted_qc>March 25, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 26, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Split, School of Medicine</investigator_affiliation>
    <investigator_full_name>Ivana Kolcic</investigator_full_name>
    <investigator_title>MD, PhD, Associate Professor in Epidemiology Centre for Global Health &amp; Department of Public Health Medical School, University of Split</investigator_title>
  </responsible_party>
  <keyword>Parents</keyword>
  <keyword>Quality of life</keyword>
  <keyword>Stress</keyword>
  <keyword>Children with developmental disability</keyword>
  <keyword>Children with chronic disease</keyword>
  <keyword>Cortisol</keyword>
  <keyword>Heart rate variability</keyword>
  <keyword>Advanced glycation end products</keyword>
  <keyword>Sleep quality</keyword>
  <keyword>Family cohesion</keyword>
  <keyword>Stigma</keyword>
  <keyword>Resilience</keyword>
  <keyword>Anxiety</keyword>
  <keyword>Depression</keyword>
  <keyword>Self Esteem</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cerebral Palsy</mesh_term>
    <mesh_term>Down Syndrome</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 1</mesh_term>
    <mesh_term>Disease</mesh_term>
    <mesh_term>Chronic Disease</mesh_term>
    <mesh_term>Autism Spectrum Disorder</mesh_term>
    <mesh_term>Developmental Disabilities</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hydrocortisone</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
    <ipd_description>Identified participants for outcome measures</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

